Organization
Array BioPharma Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Array BioPharma Inc.
... Array BioPharma Inc. (Nasdaq: ARRY) today announced the upcoming presentation of updated safety results and ...
... class action complaint has been filed on behalf of shareholders of Array Biopharma Inc. (NASDAQ:ARRY) who purchased shares between December 16, 2015 and March 17, ...
... orphan indications in the United States and Europe, today announced that Array BioPharma Inc (Array) has granted ASLAN full global rights to develop, manufacture and ...
... BOULDER, Colo., Jan.2,2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will ...
... All persons or entities who purchased or otherwise acquired securities of Array Biopharma Inc. ("Array") (NASDAQ:ARRY) between December 16, 2015 and March 17, 2017. You ...
... class action lawsuit on behalf of purchasers of the securities of Array Biopharma Inc. (NASDAQ:ARRY) from December 16, 2015 through March 17, 2017, inclusive (the ...
... timely information, WallStEquities.com has issued free tailored Stock Review on PRTK, MNKD, ARRY, and INSY which is a click away athttp://www.wallstequities.com/registration. On Tuesday, the NASDAQ ...
... Array BioPharma (Nasdaq: ARRY) announced today that it has entered into a clinical trial ...
... Array Biopharma and Pfizer have struck a clinical trial collaboration to study several ...
... the District of Colorado on behalf of investors who purchased Array Biopharma Inc. ("Array Biopharma") (NASDAQ:ARRY) securities between December 16, 2015 and March 17, 2017. ...
... All persons or entities who purchased or otherwise acquired securities of Array Biopharma Inc. ("Array") (NASDAQ:ARRY) between December 16, 2015 and March 17, 2017. You ...
... AbbVie, Inc. Alkermes Plc Amarin Corp. Plc Amgen, Inc. Amnis Corporation Array BioPharma, Inc. Associates Of Cape Cod Inc. Astex Pharmaceuticals Inc. AstraZeneca Plc ASYMPTOTE ...
... global investor rights law firm, reminds purchasers of the securities of Array Biopharma Inc. (NASDAQ:ARRY) from December 16, 2015 through March 17, 2017, inclusive (the ...
... latest key findings for all current investors, traders, and shareholders of Array BioPharma Inc. (NASDAQ:ARRY), Impax Laboratories, Inc. (NASDAQ:IPXL), Baxter International Inc. (NYSE:BAX), Timken Steel ...
... Array BioPharma Inc. (Nasdaq: ARRY) ("Array" or the "Company") today announced that it has called ...
... Wednesday, October 25. Wells Fargo has Outperform rating and $42 target. Array Biopharma Incorporated (NASDAQ:ARRY) had a decrease of 5.31% in short interest. ARRYs SI ...
... LLP, a leading national securities law firm, reminds investors in Array Biopharma, Inc. ("Array Biopharma" or the "Company") (NASDAQ: ARRY) of the January 22, 2018 ...
... All persons or entities who purchased or otherwise acquired securities of Array Biopharma Inc. ("Array") (NASDAQ:ARRY) between December 16, 2015 and March 17, 2017. You ...
... Natco Pharma, Celltrion, DexaMedica, LEO Pharma, Toyama Chemical, Sanofi, GlaxoSmithKline, Han All Biopharma, Shanghai CP Guojian Pharmaceutical, and Tsumura. Browse reports of similar category available ...
... class action lawsuit on behalf of purchasers of the securities of Array BioPharma Inc. (NASDAQ:ARRY) from December 16, 2015 through March 17, 2017, inclusive (the ...
... groups? ยท Which innovative mechanisms of action are KOLs most excited about? Array BioPharma/Roche's Akt inhibitor ipatasertib is also in the Phase III pipeline but ...
... LLP announces that a class action complaint was filed against Array BioPharma Inc. (NasdaqGM: ARRY). The complaint is brought on behalf of all purchasers of ...
... Offices of Vincent Wong notifies investors of an investigation concerning whether Array BioPharma Inc. ("Array" or the "Company") (NASDAQ:ARRY) violated federal securities laws. Click here ...
Want to see the full history on Array BioPharma Inc.? Upgrade to RelSci Pro now!
Start My Free Trial